Aprea Therapeutics, Inc. (APRE) SEC Filings & Financial Intelligence
Aprea Therapeutics, Inc. (APRE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: APRE
CIK: 1781983
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerPatrick Boyle
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-28 | 2026-08-28 | 8-K | 0001104659-26-102795 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000935836-26-000399 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001104659-26-094544 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001104659-26-094542 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | FORM 8-K | 0001104659-26-086254 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075286 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075284 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075283 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075282 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075281 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075280 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075279 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075278 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-16 | FORM 8-K | 0001104659-26-075151 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0000902664-26-002544 | View SEC Doc Filr Page |
| 424B7 | 2026-05-15 | — | 424B7 | 0001104659-26-062631 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-059743 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001104659-26-059734 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001104659-26-052063 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001104659-26-052049 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-16 | DEF 14A | 0001104659-26-052044 | View SEC Doc Filr Page |
| EFFECT | 2026-04-29 | — | EFFECT Filing | 9999999995-26-001389 | View SEC Doc Filr Page |
| 424B3 | 2026-04-29 | — | 424B3 | 0001104659-26-051739 | View SEC Doc Filr Page |
| CORRESP | 2026-04-27 | — | CORRESP Filing | 0001104659-26-049298 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-27 | — | UPLOAD Filing | 0000000000-26-004268 | View SEC Doc Filr Page |